| Date Filed | Type | Description |
| 11/21/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Disposed/sold 280,244 shares
@ $15.25, valued at
$4.3M
Disposed/sold 25,000 options to buy
@ $3.15, valued at
$78.8k
Disposed/sold 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
| 03/22/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 19,015 shares
@ $0
Granted 65,941 options to buy
@ $8.8, valued at
$580.3k
|
|
| 02/09/2022 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 701 shares
@ $7.24, valued at
$5.1k
Paid exercise price by delivering 700 shares
@ $7.33, valued at
$5.1k
|
|
| 02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 7,305 shares
@ $13, valued at
$95k
Sold 22,695 shares
@ $13.0077, valued at
$295.2k
|
|
| 02/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2019 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Exercised 117,000 options to buy
@ $0.405, valued at
$47.4k
|
|
| 02/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 11,000 shares
@ $35.2103, valued at
$387.3k
|
|
| 12/04/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 10,701 shares
@ $39.7879, valued at
$425.8k
Sold 299 shares
@ $40.5464, valued at
$12.1k
|
|
| 11/02/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 25 shares
@ $52.55, valued at
$1.3k
Sold 3,208 shares
@ $52.9936, valued at
$170k
Sold 7,792 shares
@ $54.2245, valued at
$422.5k
Exercised 3,251 options to buy
@ $0.395, valued at
$1.3k
|
|
| 10/01/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/06/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $60.0024, valued at
$600k
Sold 1,000 shares
@ $61, valued at
$61k
|
|
| 08/02/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 6,210 shares
@ $68.0024, valued at
$422.3k
Sold 4,790 shares
@ $68.6854, valued at
$329k
|
|
| 07/05/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 8,400 shares
@ $66.1457, valued at
$555.6k
Sold 2,600 shares
@ $67.0923, valued at
$174.4k
|
|
| 06/08/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 8,000 shares
@ $58.5744, valued at
$468.6k
Sold 3,000 shares
@ $59.2138, valued at
$177.6k
|
|
| 05/29/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 292 shares
@ $50.41, valued at
$14.7k
Sold 2,708 shares
@ $50.15, valued at
$135.8k
Exercised 3,000 warrants
@ $5, valued at
$15k
|
|
| 05/10/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 331 shares
@ $53.85, valued at
$17.8k
Paid exercise price by delivering 674 shares
@ $53.85, valued at
$36.3k
Paid exercise price by delivering 539 shares
@ $53.85, valued at
$29k
|
|
| 02/12/2018 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Granted 8,000 shares
@ $0
Granted 36,000 options to buy
@ $53.55, valued at
$1.9M
|
|
| 02/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2017 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 03/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2013 |
4
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Converted 18,651 shares
@ $0
Converted 3,000 warrants
@ $0
Converted 18,651 options to buy
@ $0 |
|
| 10/25/2013 |
3
| Kopczynski Casey C. (Chief Scientific Officer) has filed a Form 3 on AERIE PHARMACEUTICALS INC |